Influenza vaccines promote humoral and cellular immune responses: a randomized, double-blind, phase 3 trial.
Linmar Rodríguez-Guilarte, Constanza Méndez, Antonia Reyes, Mariana Rios, Francisca Román, Daniela Moreno-Tapia, Alex Cabrera, Daniela B Rivera, Cristián Gutiérrez-Vera, Pablo A Palacios, Andrea Schilling, Sofia Aljaro, Francisca Bascur, Álvaro Rojas, Constanza Del Río, Patricio Astudillo, Carlos M Perez, Loreto Perez, Maite Oyonarte, Patricia E Fernández Vásquez, Rosa M Feijoo, Daniel Beltrán Campos, Carlos Tovar De Sousa, Andrea Castejón, Silvana Grandón, Marcela Villarroel, Pía Jara, Loreto Twele, M Angélica Domínguez, José V González-Aramundiz, María Javiera Álvarez-Figueroa, Wanqi Yang, Qianqian Xin, Leandro J Carreño, Mario Calvo, Susan M Bueno, Hernán F Peñaloza, Pablo A González, Alexis M Kalergis
Nat Commun 17(1) 407
摘要
摘要
Annual vaccination is an effective strategy for preventing severe disease caused by seasonal influenza. Quadrivalent influenza vaccines (QIVs) protect against two strains of influenza A and two strains of influenza B, thereby enhancing the host antiviral neutralizing antibody response and inducing CD4+ and CD8+ T cell responses. Here, we report findings from a randomized, double-blind, active-controlled phase 3 clinical trial (NCT05431725) that includes 334 healthy adults aged 18-64 years and evaluates the humoral and cellular antiviral immune responses induced by two inactivated QIVs, Sinovac-QIV and Vaxigrip-Tetra™. The primary endpoint of the study is the specific antibody responses measured by hemagglutination inhibition (HAI) assays 28 days post-vaccination, while the secondary endpoint is virus-specific T cell responses. Both QIVs elicit significant increases in antibody titers 28 days after vaccination; Sinovac-QIV induces 9-10-fold increases in geometric mean titers, while Vaxigrip-Tetra™ elicits 7-8-fold increases (p < 0.05). Cellular immune responses using ELISPOT and supervised and unsupervised flow cytometry analyses show that both vaccines modulate the frequency of hemagglutinin-specific CD4+ and CD8+ T cell subsets, inducing distinct T cell response profiles. Although cellular analyses are evaluated in a subgroup of the cohort, the data indicate that both QIVs induce robust humoral and cellular immunity in adults, providing mechanistic insights into vaccine-induced protection.
KM 提取结果
0 个 Figure · 0 个 KM 面板
其他 Figure(5,默认折叠)
这些图片未产生 KM 曲线结果,不在主页面重复展示。